WGS genedx.com: Rasio nilai perusahaan marang pendapatan

GeneDx Holdings Corp. dominates the diagnosis of rare pathologies thanks to its unique genome archive. The enterprise value-to-revenue ratio on the GURU.Markets dynamic chart confirms this status, where 3301.14 serves as the base value of the parameter. Profit growth here is driven by the implementation of AI and laboratory automation, which reduces costs when scaling testing volumes.
GeneDx Corp - rincian analitis lan metrik utama (WGS)

GeneDx Holdings Corp. (WGS) dynamics in the clinical diagnostics segment and its unique genomic dataset are directly reflected in the current EV/Sales level. This multiple relates the total enterprise value, adjusted for net debt, to revenue, allowing investors to assess the risk of overpaying for assets and determine the potential for long-term return on capital without the influence of financial leverage.